Reuters logo
BRIEF-Ligand Q3 adjusted earnings per share $0.69
November 9, 2017 / 9:35 PM / in 9 days

BRIEF-Ligand Q3 adjusted earnings per share $0.69

Nov 9 (Reuters) - Ligand Pharmaceuticals Inc:

* Ligand reports third quarter 2017 financial results

* Q3 adjusted earnings per share $0.69

* Q3 earnings per share $0.36

* Q3 earnings per share view $0.61 -- Thomson Reuters I/B/E/S

* Sees FY 2017 revenue $134 million to $136 million

* Ligand Pharmaceuticals Inc - ‍total revenues for Q3 of 2017 were $33.4 million, compared with $21.6 million for same period in 2016​

* Ligand Pharmaceuticals Inc - ‍ligand updates guidance for 2017 revenue to be between $134 and $136 million​

* Ligand Pharmaceuticals Inc - ‍adjusted earnings per diluted share is now expected to be between $2.95 and $3.00 for 2017 ​

* Q3 revenue view $30.9 million -- Thomson Reuters I/B/E/S

* FY 2017 earnings per share view $2.95, revenue view $134.5 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below